Csenge Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.48M Buy
4,720
+389
+9% +$287K 0.18% 105
2025
Q1
$3.64M Sell
4,331
-273
-6% -$229K 0.21% 98
2024
Q4
$3.55M Sell
4,604
-1,370
-23% -$1.06M 0.19% 102
2024
Q3
$5.57M Buy
5,974
+408
+7% +$380K 0.29% 69
2024
Q2
$5.04M Buy
5,566
+421
+8% +$381K 0.29% 67
2024
Q1
$4M Buy
5,145
+933
+22% +$726K 0.22% 83
2023
Q4
$2.46M Buy
4,212
+73
+2% +$42.6K 0.15% 119
2023
Q3
$2.22M Buy
4,139
+9
+0.2% +$4.83K 0.15% 121
2023
Q2
$1.94M Buy
4,130
+669
+19% +$314K 0.13% 126
2023
Q1
$1.19M Sell
3,461
-14
-0.4% -$4.81K 0.09% 181
2022
Q4
$1.27M Sell
3,475
-560
-14% -$205K 0.1% 176
2022
Q3
$1.31M Buy
4,035
+26
+0.6% +$8.41K 0.11% 168
2022
Q2
$1.3M Buy
4,009
+332
+9% +$108K 0.11% 168
2022
Q1
$1.05M Buy
3,677
+1,002
+37% +$287K 0.08% 204
2021
Q4
$618K Sell
2,675
-1,655
-38% -$382K 0.06% 294
2021
Q3
$994K Buy
4,330
+1,655
+62% +$380K 0.08% 220
2021
Q2
$618K Sell
2,675
-742
-22% -$171K 0.05% 295
2021
Q1
$630K Sell
3,417
-2,163
-39% -$399K 0.06% 231
2020
Q4
$942K Sell
5,580
-951
-15% -$161K 0.11% 138
2020
Q3
$941K Buy
6,531
+333
+5% +$48K 0.13% 132
2020
Q2
$1.02M Buy
6,198
+2,320
+60% +$381K 0.15% 115
2020
Q1
$538K Buy
3,878
+108
+3% +$15K 0.14% 133
2019
Q4
$495K Buy
3,770
+194
+5% +$25.5K 0.13% 157
2019
Q3
$400K Buy
+3,576
New +$400K 0.11% 169
2019
Q1
Sell
-1,829
Closed -$211K 206
2018
Q4
$211K Buy
1,829
+1,300
+246% +$150K 0.08% 176
2018
Q3
$58K Buy
+529
New +$58K 0.02% 281